Health Catalyst Research and Development Expenses 2018-2024 | HCAT

Health Catalyst research and development expenses from 2018 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Health Catalyst Annual Research and Development Expenses
(Millions of US $)
2023 $73
2022 $76
2021 $63
2020 $54
2019 $46
2018 $39
2017 $28
Health Catalyst Quarterly Research and Development Expenses
(Millions of US $)
2024-03-31 $15
2023-12-31 $20
2023-09-30 $18
2023-06-30 $18
2023-03-31 $17
2022-12-31 $20
2022-09-30 $21
2022-06-30 $18
2022-03-31 $17
2021-12-31 $17
2021-09-30 $16
2021-06-30 $15
2021-03-31 $14
2020-12-31 $15
2020-09-30 $13
2020-06-30 $12
2020-03-31 $13
2019-12-31 $13
2019-09-30 $13
2019-06-30 $10
2019-03-31 $10
2018-12-31
2018-09-30 $11
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.401B $0.296B
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $36.987B 20.31
Inspire Medical Systems (INSP) United States $4.742B 0.00
Axonics (AXNX) United States $3.435B 0.00
10x Genomics (TXG) United States $3.214B 0.00
IRhythm Technologies (IRTC) United States $3.075B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.923B 0.00
Enovis (ENOV) United States $2.836B 21.02
Hims & Hers Health (HIMS) United States $2.769B 0.00
Azenta (AZTA) United States $2.768B 155.58
Privia Health (PRVA) United States $2.147B 119.93
Schrodinger (SDGR) United States $1.685B 0.00
Omnicell (OMCL) United States $1.414B 48.89
Phreesia (PHR) United States $1.241B 0.00
Standard BioTools (LAB) United States $0.719B 0.00
Fulgent Genetics (FLGT) United States $0.664B 0.00
Definitive Healthcare (DH) United States $0.640B 0.00
Talkspace (TALK) United States $0.484B 0.00
Clover Health Investments (CLOV) United States $0.452B 0.00
Pulmonx (LUNG) United States $0.340B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.299B 0.00
Butterfly Network (BFLY) United States $0.201B 0.00
P3 Health Partners (PIII) United States $0.199B 0.00
Outset Medical (OM) United States $0.160B 0.00
American Well (AMWL) United States $0.145B 0.00
TruBridge (TBRG) United States $0.133B 7.15
Augmedix (AUGX) United States $0.115B 0.00
MSP Recovery (LIFW) United States $0.113B 0.00
111 (YI) China $0.108B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.077B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.061B 0.00
EUDA Health Holdings (EUDA) Singapore $0.058B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
Movano (MOVE) United States $0.041B 0.00
CareCloud (CCLD) United States $0.037B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00